Within a year of quitting, many adults are at risk of falling back into their habit. While willpower and aftercare are common remedies for the unfortunate truth that is relapse, researchers at Bath, University of Surrey, and RenaSci have put a different possibility on the table. Using a chemical blocker to inhibit certain neurotransmitters used in memory, the researchers inhibited relapse from morphine in lab mice and rats. Not only this, but they tracked down areas of the brain most likely involved in the brain processes of addiction and relapse. While this is clearly far from being usable for human beings, it is promising that such an important leap in the understanding of relapse has been discovered. In time, this may lead to effective new therapies which should make the best New Jersey rehab center even better.
Relapsing into drug taking is a big problem in treating addiction, where the majority of addicts return to drug-taking within 12 months of quitting. This is brought into focus by the burgeoning ‘opioid epidemic’ of prescription as well as recreational opioid drugs, such as morphine and heroin. Addiction relapse is associated with drug-related cues such as places, drug paraphernalia, the drug itself, or stress, highlighting that memories play a key role in addiction relapse.
In this study researchers at Bath, working with colleagues from the University of Surrey and RenaSci, used an animal model to study relapse to morphine seeking behaviour. Rats or mice learned to associate particular environmental cues with morphine. After removal of the drugs, relapse back to drug-seeking behaviour occurred in response to getting the cues again. Click Here to Continue Reading